Chiujdea, S.; Ferro, M.; Vartolomei, M.D.; Lucarelli, G.; Bekku, K.; Matsukawa, A.; Parizi, M.K.; Klemm, J.; Tsuboi, I.; Fazekas, T.;
et al. Epirubicin and Non-Muscle Invasive Bladder Cancer Treatment: A Systematic Review. J. Clin. Med. 2024, 13, 3789.
https://doi.org/10.3390/jcm13133789
AMA Style
Chiujdea S, Ferro M, Vartolomei MD, Lucarelli G, Bekku K, Matsukawa A, Parizi MK, Klemm J, Tsuboi I, Fazekas T,
et al. Epirubicin and Non-Muscle Invasive Bladder Cancer Treatment: A Systematic Review. Journal of Clinical Medicine. 2024; 13(13):3789.
https://doi.org/10.3390/jcm13133789
Chicago/Turabian Style
Chiujdea, Sever, Matteo Ferro, Mihai Dorin Vartolomei, Giuseppe Lucarelli, Kensuke Bekku, Akihiro Matsukawa, Mehdi Kardoust Parizi, Jakob Klemm, Ichiro Tsuboi, Tamas Fazekas,
and et al. 2024. "Epirubicin and Non-Muscle Invasive Bladder Cancer Treatment: A Systematic Review" Journal of Clinical Medicine 13, no. 13: 3789.
https://doi.org/10.3390/jcm13133789
APA Style
Chiujdea, S., Ferro, M., Vartolomei, M. D., Lucarelli, G., Bekku, K., Matsukawa, A., Parizi, M. K., Klemm, J., Tsuboi, I., Fazekas, T., Mancon, S., & Shariat, S. F.
(2024). Epirubicin and Non-Muscle Invasive Bladder Cancer Treatment: A Systematic Review. Journal of Clinical Medicine, 13(13), 3789.
https://doi.org/10.3390/jcm13133789